|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization expense | |||||
| Allowance for credit loss on fixed maturity securities | |||||
| Loss on asset disposal | |||||
| Net realized and unrealized gains on investments | |||||
| Amortization of premium on fixed maturity securities | |||||
| Deferred income tax expense | |||||
| Deferred income tax expense (benefit) | |||||
| Changes in operating assets and liabilities: | |||||
| Accrued investment income | |||||
| Premium receivable | |||||
| Deferred policy acquisition costs | |||||
| Reinsurance recoverables | |||||
| Ceded unearned premiums | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other accrued liabilities | |||||
| Reserve for losses and loss adjustment expenses | |||||
| Unearned premiums | |||||
| Ceded premiums payable | |||||
| Funds held under reinsurance treaty | |||||
| Income taxes payable | |||||
| Net proceeds from (purchases of) derivative contracts | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Capitalized software costs | |||||
| Purchases of fixed maturity securities | |||||
| Purchases of equity securities | |||||
| Purchase of equity method investment | |||||
| Sales and maturities of fixed maturity securities | |||||
| Sales of equity securities | |||||
| Change in securities receivable or payable, net | |||||
| Investments in limited partnerships | |||||
| Acquisitions, net of cash acquired | |||||
| Purchase of policy renewal rights | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net (payments on) proceeds from line of credit | |||||
| Payments on Line of Credit | |||||
| Proceeds from Line of Credit | |||||
| Total net (payments on) proceeds from line of credit | |||||
| Proceeds from common stock issued via employee stock purchase plan | |||||
| Proceeds from common stock issued via stock option exercises | |||||
| Policy holder contribution to surplus | |||||
| Repurchase of common stock | |||||
| Proceeds from stock offering, net of offering costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplementary cash flow information: | |||||
| Cash paid for income taxes | |||||
| Cash paid for federal income taxes | |||||
| Cash paid for state income taxes | |||||
| Total cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Cash and cash equivalents and restricted cash |
Loading...